Análisis Argos
ITGR
ITGRCara
Integer Holdings Corporation · Healthcare
US$ 95.14
precio al 2026-07-04
Valor justo Argos*
US$ 43–48
vs. su valor justo
103% por encima
Score Argos
37/100
LA RESPUESTA
El mercado le pide crezca 35.4% al año — más de lo que ha demostrado (5.9%). Estás pagando un futuro que todavía no probó: el margen de error es mínimo.
Recompensas
Sin recompensas destacadas.
Riesgos
!El precio pide más crecimiento del que la empresa ha demostrado.
!Balance frágil: la deuda pesa sobre el negocio.
!Crecimiento estancado o en baja.
VALOR1/6FUTURO2/6PASADO1/6SALUD2/6DIVIDENDO2/6
El Iris de calidad
VALOR1/6FUTURO2/6PASADO1/6SALUD2/6DIVIDENDO2/6
ValorCotiza por encima de su valor justo
FuturoCrecimiento moderado
PasadoHistorial débil
SaludBalance razonable
DividendoRetorno al accionista moderado
Score Argos37de 100Cara
Ingresos8%
US$ 1.9 B
Margen operativo7%
11.3%
Flujo de caja libre10%
US$ 0.1 B
Deuda neta
US$ 1.4 B
Lo esencial, sin ruido
Cap. de mercadoUS$ 3.2B
P/E31.4x
EV/EBITDA13.8x
FCF yield3.3%
ROIC5.5%
Margen operativo11.3%
Crecim. ingresos+7.6%/año
Piotroski F4/9
Competidores

Los rivales, con el mismo ojo

El Iris de calidad de cada competidor, lado a lado. Tocá uno para ver su análisis.

Novedades

Noticias recientes

zacks.com · 4 jun
Integer Holdings 2026 Outlook: Drivers, Risks, Valuation
ITGR resets its 2026 outlook after customer forecast changes and slower product ramps, with growth and margin recovery tied to adoption timing.
globenewswire.com · 3 jun
Integer to Participate in Truist Securities 2026 MedTech Conference on June 16
PLANO, Texas, June 03, 2026 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading medical device contract development and manufacturing organization, today announced participation in the Truist Securities 2026 MedTech Conference, to be held June 16, 2026. Members of the Integer executive leadership team will participate in a fireside chat on Tuesday, June 16 at 10:40 a.m. ET.
benzinga.com · 24 may
The High-Yield Stocks the Smart Money Is Buying Right Now
There is a principle I have followed for 30 years in this business. When the smartest credit team on the planet starts aggressively buying a beaten-down asset class they understand better than anyone alive, you do not sit on your hands and debate whether the timing is perfect.
seekingalpha.com · 21 may
Integer Holdings: Rare Public Asset Soon To Be Sold
Integer Holdings Corp. is a unique, high-quality medical device CDMO trading at a depressed ~10x EBITDA multiple after a temporary growth slowdown. A strategic review, prompted by activist involvement and heightened buyer interest, positions ITGR for a likely sale within three to four months. Precedent CDMO transactions support a fair value of $110–125/share (13–14x forward EBITDA), offering 20–40% upside with limited downside risk.
fool.com · 16 may
This Medical Device Stock Is Down 25%. One Fund Just Disclosed Buying $5 Million More
Integer Holdings designs and manufactures advanced medical devices for global healthcare OEMs, serving diverse therapeutic markets.
gurufocus.com · 13 may
A Look at Integer Holdings Corp (ITGR) After 5.2% Gain -- GF Value $117.20 vs Price $89.39
On May 13, 2026, Integer Holdings Corp (ITGR) shares rose 5.2% to $89.39. The stock has experienced a 52-week range between $62.00 and $123.78, indicating signi
fool.com · 13 may
Why Integer Stock Leaped More Than 5% Higher Today
On the prospect of a potential buyout, an analyst tracking the company upgraded his recommendation.
seekingalpha.com · 12 may
Integer Holdings Corporation (ITGR) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Integer Holdings Corporation (ITGR) Presents at Bank of America Global Healthcare Conference 2026 Transcript

* Valor justo Argos: estimación educativa del valor intrínseco según el propio flujo de caja de la empresa y su capacidad de crecimiento — no un precio objetivo ni una recomendación. Esto es información y educación, no asesoría de inversión. Rendimiento pasado no garantiza resultados futuros.